40 results on '"Hale, Colin"'
Search Results
2. Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial
3. A hybrid data-driven and mechanistic model soft sensor for estimating CO2 concentrations for a carbon capture pilot plant
4. Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial
5. Are the Kids Alright? Exploring Students' Experiences of Support Mechanisms to Enhance Wellbeing on an Engineering Programme in the UK
6. Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial
7. Engaging students to shape their own learning: Driving curriculum re-design using a theory of change approach
8. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial
9. Development and Validation of a Digital Twin for the Abb-Imperial College London Carbon Capture Pilot Plant
10. Protectiveness and stability of iron carbonate films on carbon steel in mildly alkaline aqueous alkanolamine CO2 environments
11. Trace element chemistry of atmospheric deposition along the Wasatch Front (Utah, USA) reflects regional playa dust and local urban aerosols
12. A novel LC-MS/MS method for the determination of favipiravir ribofuranosyl-5’-triphosphate (T-705-RTP) in human peripheral mononuclear cells
13. Assessing the performance of UK universities in the field of chemical engineering using data envelopment analysis
14. Development and validation of an LC-MS/MS method for quantification of favipiravir in human plasma
15. Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial
16. Development, Validation and Application of an LC-MS/MS Method for Quantification of Favipiravir in Human Plasma
17. Protectiveness and Stability of Iron Carbonate Films on Carbon Steel in Mildly Alkaline Aqueous Alkanolamine Co2 Environments
18. Broadening cycling culture with the bicycle library - Planting the seeds for a new cycling culture
19. A Randomised -Controlled Phase 2 trial of Molnupiravir in Unvaccinated and Vaccinated Individuals with Early SARS-CoV-2
20. Characterisation of SARS-CoV-2 genomic variations in response to molnupiravir treatment in the AGILE Phase IIa clinical trial.
21. Finding damping loss factor using circle-fit method on Nyquist diagrams.
22. Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
23. Strontium isotope dynamics reveal streamflow contributions from shallow flow paths during snowmelt in a montane watershed, Provo River, Utah, USA
24. The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite ß-d-N4-hydroxycytidine in human plasma and saliva
25. Pharmacokinetics of β-d-N4-hydroxycytidine, the active metabolite of prodrug molnupiravir, in non-plasma compartments of patients with SARS-CoV-2 infection
26. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial
27. Glaciers Control the Hydrogeochemistry of Proglacial Streams During Late Summer in the Wind River Range, Wyoming, United States
28. An open label, adaptive, phase 1 trial of high-dose oral nitazoxanide in healthy volunteers: an antiviral candidate for SARS-CoV-2
29. Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study
30. Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a phase 1, dose-escalating, randomised controlled study
31. Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2:a Phase I, open-label, dose-escalating, randomized controlled study
32. Doing Design Differently: hybrid teaching in the age of COVID-19.
33. Trace Element Export From the Critical Zone Triggered by Snowmelt Runoff in a Montane Watershed, Provo River, Utah, USA
34. Using strontium isotopes to trace dust from a drying Great Salt Lake to adjacent urban areas and mountain snowpack
35. An Open Label, Adaptive, Phase 1 Trial of High‐Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS‐CoV‐2.
36. Are the kids alright? Exploring students’ experiences of support mechanisms to enhance wellbeing on an engineering programme in the UK
37. Are the kids alright? Exploring students' experiences of support mechanisms to enhance wellbeing on an engineering programme in the UK.
38. Teaming with Confidence: How Peer Connections in Problem-based Learning Impact the Team and Academic Self-efficacy of Engineering Students.
39. Work in Progress: Hearing You Loud and Clear: the Student Voice as a Driver for Curriculum Change in a Chemical Engineering Degree Course.
40. A THREE-PHASE SLUG FLOW INVESTIGATION BY TOMOGRAPHIC DUAL-BEAM X-RAY IMAGING: SLUG FREQUENCY MEASUREMENT AND LESSONS FOR CORRELATION DEVELOPMENT AND APPLICATION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.